Kyntra Bio KYNB
NASDAQ KYNB
$3.20 -0.29 (-8.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Kyntra Bio (KYNB) Gains from Equity Investments (2020 - 2025)

Updated

Analysis

Kyntra Bio (KYNB) Gains from Equity Investments (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Kyntra Bio 12.57 Mn -395.37 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.38 Mn
Jun 30, 2025 1.66 Mn
Mar 31, 2025 -554,000.00
Dec 31, 2024 1.31 Mn
Sep 30, 2024 898,000.00
Jun 30, 2024 1.18 Mn
Mar 31, 2024 589,000.00
Dec 31, 2023 615,000.00
Sep 30, 2023 677,000.00
Jun 30, 2023 550,000.00
Mar 31, 2023 796,000.00
Dec 31, 2022 280,000.00
Sep 30, 2022 408,000.00
Jun 30, 2022 565,000.00
Mar 31, 2022 320,000.00
Dec 31, 2021 343,000.00
Sep 30, 2021 341,000.00
Jun 30, 2021 563,000.00
Mar 31, 2021 -240,000.00
Dec 31, 2020 -189,000.00
API Access

Kyntra Bio Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=KYNB&period=max&api_key=YOUR_API_KEY